Zobrazeno 1 - 10
of 19
pro vyhledávání: '"72"'
Publikováno v:
Blood. 124:3891-3891
Blood stream infections (BSI) are a common cause of morbidity and mortality in hematopoietic cell transplant (HCT) recipients especially in the first year post transplant. With emergence of multi- drug resistant (MDR) organisms, especially enterobact
Publikováno v:
Blood. 118:2097-2097
Abstract 2097 Anemia of inflammation (AI) has been widely associated with chronic rheumatologic, infectious, and cardiovascular disorders and comprises one-third of cases of anemia in the elderly. Although the antimicrobial peptide hepcidin is felt t
Autor:
Roger M. Lyons, Martha Arellano, David F. Claxton, Stefan Faderl, Janice Gabrilove, Dirk Huebner, Stephen Eckert, Harry P. Erba, Hagop M. Kantarjian, Tibor Kovacsovics
Publikováno v:
Blood. 114:2061-2061
Abstract 2061 Poster Board II-38 Background: We have previously reported efficacy and safety of clofarabine in patients = 60 with at least one unfavorable prognostic factor. Retrospective analyses have suggested that survival in AML is related to qua
Autor:
Peter L. Perrotta, Thomas F. Hogan, Mudussara Khan, Ramin Altaha, Vijaya Gadiyaram, Edward B. Crowell, Gerald R. Hobbs
Publikováno v:
Blood. 112:4500-4500
Background: One or more risk factors for deep vein thrombosis (DVT) and pulmonary embolism (PE), either hereditary or acquired, can be identified in up to 80% of patients with venous thromboembolism (VTE). Some patients have more than one form of inh
Autor:
Vanderson Rocha, Gérard Socié, Yulia Skvortsova, Raphaël Porcher, Carmen Bonfim, Marco A. Bittencourt, Eliane Gluckman, Marco Antonio Zago, Juliana F Fernandes, Marli Tavela, Ricardo Pasquini, Moema Santos
Publikováno v:
Blood. 110:1981-1981
Fanconi anaemia (FA) patients are known to have a markedly increased toxicity of chemotherapeutic agents, due to impairment in various important cellular processes, such as DNA repair. This toxicity had led to several alterations in preparative regim
Autor:
Caroline Braggins, Joseph Cappuccio, Richard F. Raubertas, Margaret Gallagher, Ronald L. Sham, Pradyumna D. Phatak
Publikováno v:
Blood. 96:3707-3711
Screening for hereditary hemochromatosis (HHC) by means of transferrin saturation (TS) levels has been advocated and will identify many patients who are asymptomatic. The purposes of this study were (1) to determine HFE genotypes among asymptomatic H
Autor:
Elena Rossi, Katia Paciaroni, Marco Molinari, Pietro Attilio Tonali, Serenella Servidei, Giuseppe Leone, Valerio De Stefano, I Casorelli, Patrizia Chiusolo
Publikováno v:
Scopus-Elsevier
The factor II G20210A mutation is a recently identified congenital risk factor for venous thrombosis. Its role in artery disease is still undefined. We investigated 72 patients (35 male and 37 female) with documented ischemic stroke occurred before 5
Autor:
Zinaida Good, Astraea Jager, Giuseppe Gaipa, Andrea Biondi, Garry P. Nolan, Jolanda Sarno, Kara L. Davis
Publikováno v:
Blood. 126:2616-2616
Numerous studies have demonstrated the association between minimal residual disease (MRD) positivity and risk of eventual relapse for children with B cell precursor acute lymphoblastic leukemia (BCP ALL). Yet despite varied methods to detect MRD (flo
Publikováno v:
Blood. 126:5231-5231
Background: Telomere is a repeatitive sequence at the chromosome end, functioning as a cap, and the length of telomere becomes shortened after each cell devision, eventually going to senescence. Thus, the length of telomere reflects the proliferative
Autor:
Ralf Knoefler, Christine Heller, Gili Kenet, Rolf M. Mesters, Susan Halimeh, Ulrike Nowak-Göttl, Verena Limperger, Karin Kurnik
Publikováno v:
Blood. 124:583-583
Background: Venous thromboembolism [TE] is a multifactorial disease and antithrombin [ATD] -, protein C [PCD] - or protein S [PSD] -deficiency constitutes a major risk factor. The objective of the present study was to i) evaluate the prevalence of AT